How Many Units Is 15 mg of Tirzepatide? (Maximum FDA Dose)

How many units is 15 mg of tirzepatide depends on your vial's concentration. At the most common 10 mg/ml concentration, 15 mg of tirzepatide equals 150 units, which exceeds a single 1 ml insulin syringe (max 100 units). At 20 mg/ml, 15 mg equals 75 units, which fits in a 1 ml syringe. At 5 mg/ml, 15 mg equals 300 units, requiring multiple draws. The 15 mg dose is the FDA-approved maximum for both Mounjaro and Zepbound. Checkout this GLP-1 dose calculator for better insights.

Quick Answer Table: 15 mg Tirzepatide to Units

The 15 mg dose is the FDA-approved maximum tirzepatide dose and the final titration step. Many patients reach this dose around week 21 and stay on it long-term as maintenance.

Here is what to know up front about 15 mg tirzepatide units. The 15 mg dose is the tirzepatide max dose approved by the FDA for both Mounjaro and Zepbound, per the FDA prescribing information. At 10 mg/ml (most common), it requires 150 units, which exceeds a single 1 ml insulin syringe. The 20 mg/ml concentration is more practical at this dose, requiring 75 units that fit a standard 1 ml syringe. Doses above 15 mg are not FDA-approved and have limited long-term safety data. For broader context, see compounded tirzepatide dosage.

The Math: How We Calculated This

The formula for compounded tirzepatide 15mg to units is:

Units = (mg dose ÷ concentration in mg/ml) × 100

Worked example at 10 mg/ml (most common):

15 mg ÷ 10 mg/ml = 1.5 ml 1.5 ml × 100 = 150 units (exceeds a 1 ml syringe)

At 20 mg/ml: 15 ÷ 20 = 0.75 ml = 75 units (fits a 1 ml syringe comfortably)

At 5 mg/ml: 15 ÷ 5 = 3.0 ml = 300 units (requires three separate 1 ml draws)

The 15mg to units conversion is most practical at 20 mg/ml. Most compounding pharmacies switch patients to 20 mg/ml when they reach the higher titration doses (12.5 mg and above).

Why 15 mg Is the Maximum

The FDA approved 15 mg as the maximum tirzepatide dose based on Phase 3 clinical trial data showing:

• 5 mg, 10 mg, and 15 mg all provided meaningful weight loss in clinical trials

• 15 mg produced the strongest weight loss results, around 22.5% body weight loss in 72 weeks

• Safety profile remained acceptable at 15 mg

• Higher doses (above 15 mg) were not tested in major Phase 3 trials

Doses above 15 mg are sometimes available through compounding pharmacies but are not FDA-approved. Long-term safety data for compounded tirzepatide above 15 mg is limited. Patients on doses above 15 mg need direct physician oversight.

For the 15 mg dose itself, both Mounjaro (for type 2 diabetes) and Zepbound (for weight loss and obesity) include 15 mg as the maximum recommended weekly dose.

How to Read the Syringe for 15 mg

The tirzepatide 15 mg syringe choice has practical implications.

At 20 mg/ml (75 units): Use a 1 ml insulin syringe. The 75 unit mark sits three-quarters up the barrel. This is the most practical approach at the max dose. Most pharmacies dispense at 20 mg/ml for patients reaching 15 mg.

At 10 mg/ml (150 units): Requires two-stage draws. Use two 1 ml insulin syringes. First syringe: draw to 100 units, inject. Second syringe: draw 50 units, inject in a different site. Two injections on the same day.

At 5 mg/ml (300 units): Three separate draws of 100 units each. Not practical for routine weekly use. Switch concentrations.

For full guidance on syringe sizes, see how to read insulin syringe units.

Common Mistakes With 15 mg Conversion

Trying to draw 150 units in a 1 ml syringe. A standard 1 ml insulin syringe holds only 100 units. Forcing 150 units cannot work physically. Use two draws or a higher-concentration vial.

Misreading a 1 ml syringe as 1.5 ml. Some patients see a 1 ml syringe filled and assume it holds enough for a 1.5 ml dose. The maximum capacity is 1 ml (100 units), regardless of how full the syringe appears.

Combining draws from different vials. Never mix tirzepatide from two vials with different concentrations in a single dose. The conversion math becomes uncertain and dosing accuracy suffers.

Self-escalating above 15 mg. Some patients pursue doses above 15 mg seeking faster results. These compounded high doses are not FDA-approved and have limited long-term safety data. Only escalate above 15 mg with explicit physician direction.